U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033624) titled 'Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study' on June 13.
Brief Summary: The aim of this prospective cohort study is to collect the multi-omics profile of cardiovascular disease (CVD) high-risk individuals in Harbin, and to discover novel biomarker signatures of major adverse cardiovascular events (MACE) during a minimum 2-year follow-up period.
Study Start Date: July 01
Study Type: OBSERVATIONAL
Condition:
Cardiovascular Diseases
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Harbin Medical University
Information provided by (Responsible Party): Yu Bo, Harbin Medical University
Pub...